|Market Size in 2018||Market Forecast in 2026||CAGR (in %)||Base Year|
|USD 9.74 Billion||USD 13.91 Billion||5.4%||2018|
Research Antibodies Market
Global demand for research antibodies market was valued at approximately USD 9.74 billion in 2018 and is expected to generate revenue of around USD 13.91 billion by end of 2025, growing at a CAGR of around 5.4% between 2019 and 2025.
The report covers forecasts and analysis for the research antibodies market on a global and regional level. The study provides historic data from 2016 along with forecasts from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the research antibodies market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the research antibodies market on a global as well as regional level.
In order to give the users of this report a comprehensive view of the research antibodies market, we have included a competitive landscape and analysis of Porter’s Five Forces application for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis in order to give a broader overview of the key players in the research antibodies market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the research antibodies market on a global and regional basis.
The study provides a crucial view of the research antibodies by segmenting the market based on product, technology, application, end-user, and region. All the segments of the research antibodies market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.
Antibodies also called immunoglobulin are proteins prepared by B cells of the immune system. The antibodies recognize foreign substances or antigens and bind to the epitope regions of antigens and flag them for destruction. Thus it helps in protecting the body from foreign invasion. The antibodies can be constructed in the laboratory through recombinant DNA technology. The ability of immunoglobulin to recognize and bind to specific molecular structures or sequences makes it the ideal tool for cell research and protein function studies for the isolation of molecules of interest.
The demand for the research antibodies market is driven by increasing cell-based research and development activities, genomics and proteomics research for the development of new protein therapeutics, increasing acceptance of personalized medicine, growing collaborations between industries and academic institutes, increasing focus on new biomarker development, etc. However, time-intensive antibody development methods and cost are major factors that may restrain the market growth along with quality concerns. Emerging markets are expected to bring new growth opportunities for major manufacturers of research antibodies. Growth in the biopharmaceutical industry and increasing R&D spending in emerging markets may open new avenues for the research antibodies market.
Based on product, the global research antibodies market is bifurcated into reagents and antibodies. The reagents segment accounted for the largest market share in 2018 whereas the antibodies segment is expected to grow at the highest CAGR over the forecast period. Continuous and large volume use of reagents for routine assays has attributed to the largest market share of reagents. Increasing the use of antibodies for research in various application areas such as oncology, stem cell research, immunology, infectious diseases, etc. will help to register the highest CAGR over the forecast period. Based on the type of antibodies product segment is categorized into secondary and primary antibodies. Based on source antibodies product segment is categorized into rabbit, mouse, and others. Based on research applications antibodies product segment is categorized into infectious diseases, oncology, immunology, and other applications.
Enzyme-linked immunosorbent assay (ELISA), flow cytometry, immunohistochemistry, immunoprecipitation, immunofluorescence, western blotting, and others constitute the technology segment of the global research antibodies market. The western blotting technology segment dominated the market with the largest revenue share in 2018. Western blotting technology allows quantification at as low as 0.1 nanogram level and thus is widely used technology across the globe. Enzyme-linked immunosorbent assay technique is expected to grow at the highest CAGR over the forecast period.
Based on applications market is segmented into genomics, drug development, proteomics, and other applications. The proteomics application segment held the largest market share in 2018. This large share is attributed to the increasing demand for proteomic-based approaches in cancer profiling and biomarker selection, increasing R&D spending, and government grants for proteomics research.
The end-user segment is divided into include contract research organizations, academic & research institutes, and pharmaceutical & biotechnological companies. Pharmaceutical & biotechnological companies were the largest end users of the research antibodies market in 2018. Availability of funds, increasing R&D activities for new therapeutics development, and drug discovery and development process attribute to the largest market share of pharmaceutical & biotechnological companies.
North America dominated the global research antibodies market in 2018. The presence of major manufacturers, availability of funds, presence of developed R&D infrastructure, increasing demand for personalized medicine, technological advancements in immunology and proteomics research, increasing chronic disease burden, etc. are factors driving the market in this region. Europe was the second dominating market. The presence of developed infrastructure, availability of budgets, and increasing R&D spending for drug discovery and development services are factors that boost the market growth in this region. Latin America is expected to register application rate growth over the forecast period. Asia Pacific region will be a highly growing market for research antibodies. Pharmaceutical and biopharmaceutical industry growth in emerging countries like India and China, the wide presence of contract research organizations, and government initiatives to promote proteomics research are expected to propel market growth in the Asia Pacific. Middle East and Africa will register slower growth compared to other regions due to a lack of infrastructure and funds.
|Report Attributes||Report Details|
|Report Name||Research Antibodies Market Size Report|
|Market Size in 2018||USD 9.74 Billion|
|Market Forecast in 2026||USD 13.91 Billion|
|Growth Rate||CAGR of 5.4%|
|Number of Pages||188|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Key Companies Covered||Merck Group, Thermo Fisher Scientific, Inc., Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., GenScript, Danaher Corporation, Lonza, PerkinElmer, Inc., Becton, Dickinson and Company, and BioLegend, Inc. among others.|
|Segments Covered||By Product, By Technology, By Application And By Region.|
|Historical Year||2015 to 2018|
|Forecast Year||2019 - 2025|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
Major players included in the report are:
The report segment of the global research antibodies market is as follows:
Global demand for research antibodies market was valued at approximately USD 9.74 billion in 2018 and is expected to generate revenue of around USD 13.91 billion by end of 2025
growing at a CAGR of around 5.4% between 2019 and 2025.